- Home
- ALDX vs RFI Comparison
ALDX vs RFI Comparison
Compare ALDX & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- RFI
- Stock Information
- Founded
- ALDX 2004
- RFI 1992
- Country
- ALDX United States
- RFI United States
- Employees
- ALDX N/A
- RFI N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- RFI Investment Managers
- Sector
- ALDX Health Care
- RFI Finance
- Exchange
- ALDX Nasdaq
- RFI Nasdaq
- Market Cap
- ALDX 304.9M
- RFI 311.2M
- IPO Year
- ALDX 2014
- RFI N/A
- Fundamental
- Price
- ALDX $5.40
- RFI $11.89
- Analyst Decision
- ALDX Strong Buy
- RFI
- Analyst Count
- ALDX 2
- RFI 0
- Target Price
- ALDX $10.00
- RFI N/A
- AVG Volume (30 Days)
- ALDX 394.0K
- RFI 69.8K
- Earning Date
- ALDX 03-06-2025
- RFI 01-01-0001
- Dividend Yield
- ALDX N/A
- RFI 8.25%
- EPS Growth
- ALDX N/A
- RFI N/A
- EPS
- ALDX N/A
- RFI N/A
- Revenue
- ALDX N/A
- RFI N/A
- Revenue This Year
- ALDX N/A
- RFI N/A
- Revenue Next Year
- ALDX N/A
- RFI N/A
- P/E Ratio
- ALDX N/A
- RFI N/A
- Revenue Growth
- ALDX N/A
- RFI N/A
- 52 Week Low
- ALDX $2.71
- RFI $9.62
- 52 Week High
- ALDX $6.55
- RFI $12.52
- Technical
- Relative Strength Index (RSI)
- ALDX 60.04
- RFI 50.44
- Support Level
- ALDX $4.95
- RFI $11.69
- Resistance Level
- ALDX $5.10
- RFI $11.99
- Average True Range (ATR)
- ALDX 0.24
- RFI 0.16
- MACD
- ALDX 0.04
- RFI 0.04
- Stochastic Oscillator
- ALDX 85.06
- RFI 69.12
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
About RFI Cohen & Steers Total Return Realty Fund Inc.
Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.